Caladryl is a market leader in the Anti Allergy and Anti Itch topical application segment. It is India’s most prescribed Anti skin allergy and anti skin irritation solution by doctors*.
The product has a cooling sensation on application and is effective against prickly heat, insect bites, sunburns and skin irritations.

Need State:
The tropical climate of India leads to multiple challenges for the skin. Excessive sweating or moisture accumulation due to blocked pores leads to skin irritations and allergies with a strong urge to scratch. Besides the physical discomfort to the body, it also creates a fear of the condition worsening into an infection and spreading to other body parts or to other family members
Here’s what happens.
A normal functioning pore allows the moisture/sweat to evaporate while a blocked pore leads to accumulation of moisture/sweat under the skin surface. The skin suffers from redness, swelling and pus formation. The need is to dry out the accumulated fluid non intrusively

Key Ingredients:
Caladryl is a topical lotion containing Diphenhydramine and Calamine
Caladryl contains:
Calamine I.P 8% w/v
Diphenhydramine Hydrochloride I.P 1% w/v
Ethanol (95%) I.P 2.37% v/v

How does it work:
Caladryl helps heal an irritated skin by the following mechanisms

  • It reduces sweat, moisture, pus and other fluid accumulation. This helps in reducing the swelling and prevents germs from breeding in the affected area
  • It reduces redness and itching
  • It forms a physical barrier over the affected area. This prevents any harmful substance from coming in direct contact with skin, thus accelerating the healing process.

Directions for use:
Wash the affected area thoroughly with water. Dab Caladryl lightly on the affected area using cotton or fingers. It should not be rubbed into the skin and it should be ensure that the lotion has dried before covering the affected area.

Pack Size:
Caladryl Lotion is available in 50ml and 100ml packs

Where to buy:
Available at all leading chemist outlets across India

*As per IMS prescription audit MAT Jul’13 period for topical antipruritics (D 4A 1)

Bottom curve